DrugsControl Media Services

News Detail

Dual Checkpoint Inhibition Boost from New Bifunctional Antibody (05-03-2018)

Baltimore, 2 March 2018: Researchers at Johns Hopkins University School of Medicine have developed a new class of bifunctional antibody-based immunotherapy that targets immune checkpoints, but simultaneously disables the production of immunosuppressive regulatory T cells (Tregs).......
View Details

Source : Genetic Engineering & Biotechnology News

Related News